Ewa Marszal

Subvisible Particle Content, Formulation, and Dose of an Erythropoietin Peptide Mimetic Product Are Associated With Severe Adverse Postmarketing Events

Joseph A. Kotarek, Christine Stuart, Silvia H. De Paoli et al. · Journal of Pharmaceutical Sciences · 2016 · 115 citations · Full text

Medicine, Pharmacotherapy, Pharmacology +1

Analyzing Subvisible Particles in Protein Drug Products: a Comparison of Dynamic Light Scattering (DLS) and Resonant Mass Measurement (RMM)

Jainik Panchal, Joseph A. Kotarek, Ewa Marszal et al. · The AAPS Journal · 2014 · 99 citations · Full text

Dynamic Light Scattering, Biochemistry, Subvisible Particles +10

Meeting report on protein particles and immunogenicity of therapeutic proteins: Filling in the gaps in risk evaluation and mitigation

John Carpenter, Barry Cherney, Anthony Lubinecki et al. · Biologicals · 2010 · 66 citations

Vaccination, Cross-protection, Allergy +8

Physical Characterization and Innate Immunogenicity of Aggregated Intravenous Immunoglobulin (IGIV) in an In Vitro Cell-Based Model

Ehab M. Moussa, Joseph A. Kotarek, Jodi Switzer Blum et al. · Pharmaceutical Research · 2016 · 33 citations

Inflammation, Vitro Cell-based Model, Allergy +12

Workshop on predictive science of the immunogenicity aspects of particles in biopharmaceutical products

Ewa Marszal, Elizabeth Fowler · Journal of Pharmaceutical Sciences · 2012 · 13 citations

Vaccination, Immunogenicity Aspects, Immunocytochemical Technique +10